Vice President JD Vance has formally requested the Justice Department to investigate dozens of hospitals nationwide over allegations of fraudulent billing practices related to gender-affirming care for minors. The request follows the release of a Department of Health and Human Services (HHS) report titled Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of 'Gender Medicine.'
The HHS report alleges that pediatric gender clinics and children’s hospitals may have misused diagnostic and billing codes to secure insurance coverage for procedures such as puberty blockers, hormone therapy, and gender surgeries for minors. These practices, the report claims, resulted in potential fraud totaling nearly $50 million across private insurers and Medicaid programs. The report identifies more than 225 hospitals and health systems that established pediatric gender clinics between 2015 and 2025, with some allegedly using codes like 'endocrine disorder, unspecified' and 'precocious puberty' to justify billing for transgender-related treatments.
Vance, who heads the White House Anti-Fraud Task Force, sent a letter to Attorney General Todd Blanche on Thursday, urging the Department of Justice (DOJ) to launch a criminal investigation. In a post on X (formerly Twitter), Vance stated that hospitals may have subjected children to 'horrific, experimental treatments' while defrauding insurers through misleading billing practices. The report also references a short documentary produced by HHS featuring testimonials from individuals who said they regretted receiving gender-affirming care as minors, though the report does not provide further details on these claims.
HHS Report Details and Allegations
The 64-page HHS report, obtained by the Washington Examiner, outlines how hospitals allegedly systematically misdiagnosed minors to bill for procedures such as mastectomies, vaginoplasty, and cross-sex hormone therapy. The report argues that these practices were not only medically questionable but also financially motivated, with providers exploiting federal and private insurance programs. HHS Secretary Robert F. Kennedy, Jr. stated in a press release that the report identifies 'troubling billing practices' that warrant scrutiny, emphasizing that 'doctors and hospitals must put children’s health ahead of ideology and financial gain.'
The report also highlights the use of 'precocious puberty' as a diagnostic code for minors receiving puberty blockers, a treatment typically reserved for rare medical conditions. While the report does not dispute the medical use of puberty blockers for precocious puberty, it suggests that the expanded application to gender-affirming care may have been misrepresented for financial gain.
Reactions from Medical Organizations
Several leading medical organizations have criticized the HHS report and the CMS funding cuts, arguing that the allegations are baseless and could harm patients. The American Medical Association (AMA) and the American Academy of Pediatrics (AAP) have both stated that gender-affirming care is medically necessary and supported by evidence. In a statement, AAP President Susan J. Kressly warned that allowing the government to determine which patient groups deserve care sets a dangerous precedent, adding that 'children and families will bear the consequences.'
The Centers for Medicare and Medicaid Services (CMS) recently announced that it would cut off Medicaid funding to hospitals offering gender-affirming care for minors, a decision that has drawn legal challenges from medical groups. The CMS action was framed as a response to concerns about patient safety and the appropriateness of treatments, though critics argue it is based on political rather than medical grounds.
Legal and Policy Implications
The HHS report has referred the implicated hospitals to the DOJ and the HHS Office of Inspector General for potential violations of federal law, including fraud and false claims. If substantiated, the allegations could result in civil or criminal liability for the hospitals involved. The report also raises broader questions about the regulation of pediatric gender clinics and the oversight of experimental medical procedures for minors.
Vance’s request for a DOJ investigation adds momentum to ongoing debates about gender-affirming care policies, particularly in states where such treatments have been banned or restricted. The outcome of any investigation could have significant legal and financial repercussions for the hospitals named in the report, as well as far-reaching implications for the future of gender-affirming care in the U.S.